Learn how Cleveland Clinic is advancing gastrointestinal care: Examining the link between IBD and liver disease, predicting progression in Barrett’s esophagus and investigating stem cell therapy for Crohn’s disease.
A recently developed systems pathology test effectively identifies nondysplastic Barrett’s esophagus patients who are at increased progression risk and would benefit from more frequent surveillance and potential intervention, according to a Cleveland Clinic-led independent validation study.
Miguel Regueiro, MD, Chair of Cleveland Clinic’s Department of Gastroenterology, Hepatology and Nutrition, highlights six can’t-miss DDW presentations by our researchers.
An actively enrolling clinical trial hopes to find out whether a swallowable capsule can gather a sample and assay methylated DNA biomarkers to diagnose BE and esophageal cancer.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
From Barrett’s esophagus and early esophageal cancer to GERD, esophagitis and esophageal motility disorders, here’s a look at what’s new. Dr. Prashanthi N.Thota explains.
In this video, Cleveland Clinic’s Chair of the Department of Pathology discusses a series of esophageal biopsies.